La copia oculta de ADN puede dar a las bacterias una vía más rápida a la resistencia a los antibióticos

Hidden DNA copying may give bacteria a faster route to antibiotic resistance Scientists have uncovered a novel mechanism by which bacteria rapidly acquire resistance to antibiotics, potentially accelerating the spread of drug-resistant strains. Researchers from Technion's Faculty of Biology, led by Dr. Idan Yelin and Prof. Roy Kishony, have identified a previously unrecognized method of gene duplication that allows bacteria to enhance their survival capabilities, including resistance to commonly used antibiotics. Their findings, published in Nature Microbiology, reveal that this mechanism enables bacteria to produce multiple copies of resistance-related genes in a highly efficient manner, offering a potential explanation for the increasing prevalence of antibiotic-resistant infections. The study focused on two bacterial species, Escherichia coli and Acinetobacter baumannii, and examined how they responded to exposure to the antibiotic chloramphenicol. By utilizing a newly developed computational tool called AmpliFinder, the researchers analyzed over 10,000 laboratory-evolved bacterial samples. They observed that certain DNA segments, particularly those containing the mdfA gene, were being amplified at an unprecedented rate. This process, termed noncanonical gene amplification, involves duplicating genes through a single DNA segment that links distant parts of the genome, making it challenging to detect using traditional methods. This discovery challenges conventional understanding of gene amplification, which typically relies on repetitive sequences flanked by identical mobile genetic elements. The researchers initially anticipated that noncanonical structures would be rare and less effective. However, they found that these structures are widespread among bacteria and function more efficiently than canonical ones. According to Yelin, these noncanonical amplifications appear to be the dominant mode of gene duplication in bacterial populations, providing a critical advantage in the face of environmental pressures such as antibiotic exposure. The implications of this mechanism extend beyond basic microbiology. The ability of bacteria to rapidly amplify resistance genes means that they can adapt to higher antibiotic concentrations more swiftly than previously believed. In experiments, the researchers demonstrated that repeated exposure to increasing levels of chloramphenicol resulted in enhanced resistance, driven by the amplification of the mdfA gene. This suggests that the mechanism not only strengthens existing resistance but also facilitates the emergence of new resistance traits, further complicating efforts to control antibiotic resistance. The study highlights the urgent need for new therapeutic approaches aimed at disrupting this mechanism. By targeting the pathways responsible for noncanonical gene amplification, scientists may be able to slow or halt the development of antibiotic resistance, preserving the efficacy of current treatments. The researchers emphasize that understanding this process is essential for developing strategies that counteract the growing threat of multidrug-resistant infections. As the global healthcare community continues to grapple with the consequences of antibiotic overuse, this discovery underscores the importance of vigilance in antibiotic stewardship. The findings also raise questions about the broader role of evolutionary processes in shaping microbial adaptation, prompting renewed interest in how biological principles can inform medical practice and policy. With ongoing research into this phenomenon, the scientific community hopes to translate these insights into practical solutions that address one of the most pressing challenges in modern medicine.